Antonio Pérez Martínez-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

    Anales de Pediatria, Vol. 97, Núm. 2, pp. 130.e1-130.e7

2021

  1. The race of CAR therapies: CAR-NK cells for fighting B-cell hematological cancers

    Cancers, Vol. 13, Núm. 21

2020

  1. Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

    BMJ Open, Vol. 10, Núm. 1

2017

  1. Early clinical trials in paediatric oncology in Spain: a nationwide perspective

    Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163

  2. Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacional

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 87, Núm. 3, pp. 155-163